OKYO Pharma Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	4.22	1.56	0.83	4.05	2.7	6.89
Cash & Short-Term Investments	4.22	1.56	0.83	4.05	2.7	6.89
Cash Growth	327.51%	88.78%	-79.56%	49.70%	-60.78%	2823.37%
Other Receivables	0.42	2.11	0.71	1.15	1.6	0.1
Total Trade Receivables	0.42	2.11	0.71	1.15	1.6	0.1
Total Current Assets	4.64	3.68	1.54	5.2	4.3	6.99
Net Property, Plant & Equipment	0	0	0	0.01	0.01	0.1
Total Assets	4.64	3.68	1.54	5.2	4.3	7.09
Accounts Payable	7.87	9.23	7.42	5.04	1.35	1.67
Short-Term Debt	0.19	-	-	2.22	-	-
Current Portion of Leases	-	-	-	-	-	0.03
Total Current Liabilities	8.06	9.23	7.42	7.26	1.35	1.71
Total Liabilities	8.06	9.23	7.42	7.26	1.35	1.71
Additional Paid-in Capital	154	148.95	147.96	135.1	103.98	121.5
Accumulated Other Comprehensive Income	-11.8	-11.47	-11.31	-11.45	-0	-10.17
Retained Earnings	-145.61	-143.03	-142.52	-125.7	-101.03	-106
Shareholders' Equity	-3.42	-5.55	-5.88	-2.05	2.95	5.32
Total Liabilities & Equity	4.64	3.68	1.54	5.2	4.3	7.09
Total Debt	0.19	0	0	2.22	0	0.03
Net Cash (Debt)	4.03	1.56	0.83	1.83	2.7	6.86
Net Cash Growth	158.48%	88.78%	-54.82%	-32.27%	-60.58%	2873.16%
Net Cash Per Share	6.33	2.57	1.83	5.34	11.66	43.05
Book Value	-3.42	-5.55	-5.88	-2.05	2.95	5.32
Book Value Per Share	-5.36	-9.13	-13.02	-6.00	12.72	33.41
Tangible Book Value	-3.42	-5.55	-5.88	-2.05	2.95	5.32
Tangible Book Value Per Share	-5.36	-9.13	-13.02	-6.00	12.72	33.41

SEC Filings: 10-K · 10-Q